http://phys.org/ en-us Phys.org internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine. Patients suffering from B-cell lymphomas can be treated with antibodies directed against the B-lymphocyte antigen CD20. http://phys.org/news238738590.html Chemistry Tue, 25 Oct 2011 05:16:47 EST news238738590 What happens when two proteins join together? In this case, they become like a power couple, where the whole is greater than the sum of the parts. http://phys.org/news215359780.html Medicine & Health Thu, 27 Jan 2011 14:10:39 EST news215359780 Researchers have identified a mutation in a gene that could lead to targeted therapies for certain lymphoma patients whose cure rates are currently poor. Mutation of the MYD88 gene was found to be one of the most frequent genetic abnormalities in a form of cancer known as diffuse large B cell lymphoma. MYD88 encodes a protein that is crucial for the normal immune response to invading microorganisms. New experiments show a mutation in the MYD88 protein sequence can cause uncontrolled cellular signaling, leading to survival of malignant cells. The study, led by researchers from the National Cancer Institute (NCI), part of the National Institutes of Health, appeared online in Nature, Dec. 22, 2010. http://phys.org/news212249881.html Medicine & Health Wed, 22 Dec 2010 14:19:19 EST news212249881 Scripps Research Institute scientists have discovered a new way to target and destroy a type of cancerous cell. The findings may lead to the development of new therapies to treat lymphomas, leukemias, and related cancers. http://phys.org/news195147259.html Medicine & Health Mon, 07 Jun 2010 18:10:01 EST news195147259 Medical Research Council (MRC) scientists at the University of Leicester have made a new advance in understanding how the body fights certain types of cancer and other disease such as Lupus and rheumatoid arthritis. http://phys.org/news187531958.html Medicine & Health Thu, 11 Mar 2010 12:40:01 EST news187531958 (AP) -- Microsoft Corp. co-founder and billionaire investor Paul Allen has been diagnosed with non-Hodgkin's lymphoma and is undergoing chemotherapy. http://phys.org/news177656394.html Technology Tue, 17 Nov 2009 05:04:46 EST news177656394 A small group of patients with severe Graves' eye disease experienced rapid improvement of their symptoms — and improved vision — following treatment with the drug rituximab. Inflammation around their eyes and damage to the optic nerve were significantly reduced. The same patients had not previously responded to steroids, a common treatment for Graves' eye disease. http://phys.org/news176737372.html Medicine & Health Fri, 06 Nov 2009 13:43:30 EST news176737372 Researchers have identified that Rituxan, a drug previously approved for the treatment of non-Hodgkin's B cell lymphoma and rheumatoid arthritis, can treat severe ANCA-associated vasculitis as effectively as cyclophosphamide, the current standard therapy. The news will be presented October 18 at the annual meeting of the American College of Rheumatology in Philadelphia. http://phys.org/news175081132.html Medicine & Health Sun, 18 Oct 2009 10:39:42 EST news175081132 As the body creates antibodies to fight invaders, a three-protein DNA repair complex called MRN is crucial for a normal gene-shuffling process to proceed properly, University of Michigan research shows. http://phys.org/news168678106.html Biology Wed, 05 Aug 2009 08:50:01 EST news168678106 Expression of a single gene programs an immune system helper T cell that fuels rapid growth and diversification of antibodies in a cellular structure implicated in autoimmune diseases and development of B cell lymphoma, scientists at The University of Texas M. D. Anderson Cancer Center reported today in Science Express, the advance online publication of the journal Science. http://phys.org/news167578949.html Medicine & Health Thu, 23 Jul 2009 15:30:01 EST news167578949 (PhysOrg.com) -- Effective drugs for treating a chemotherapy-resistant form of lymphoma might already be on the market according to a study that has pieced together a chemical pathway involved in the disease. http://phys.org/news165085198.html Medicine & Health Wed, 24 Jun 2009 22:00:01 EST news165085198 When combined with a cocktail of chemotherapy drugs, two monoclonal antibodies, instead of one, appear to offer superior results in patients with diffuse large B-cell lymphoma, according to Mayo Clinic researchers working with the North Central Cancer Treatment Group (NCCTG). http://phys.org/news161606164.html Medicine & Health Fri, 15 May 2009 11:36:26 EST news161606164 Pre-diagnostic wine consumption may reduce the risk of death and relapse among non-Hodgkin's lymphoma patients, according to an epidemiology study presented at the American Association for Cancer Research 100th Annual Meeting 2009. http://phys.org/news159546195.html Medicine & Health Tue, 21 Apr 2009 15:23:44 EST news159546195